RecruitingNCT06142669

EVOLUTION® Revision STEMMED CS Post Market Clinical Follow-up Study Protocol

Post Market Clinical Follow-Up Study for EVOLUTION® Revision Tibial System and EVOLUTION® Stemmed CS Femur With the EVOLUTION® MP CS Tibial Insert


Sponsor

MicroPort Orthopedics Inc.

Enrollment

45 participants

Start Date

Oct 31, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

MicroPort (MPO) is conducting this PMCF study to evaluate the safety and effectiveness of its EVOLUTION® Revision Tibial System and EVOLUTION® Revision STEMMED CS Femur with the EVOLUTION® MP CS Tibial Insert. This type of study is required by regulatory authorities for all devices that have been approved in Europe to evaluate the medium and long-term clinical evidence.


Eligibility

Min Age: 21 Years

Inclusion Criteria5

  • Has previously undergone or currently has been determined to undergo a revision knee arthroplasty that requires implantation of the components under study (EVOLUTION® Revision Tibial System and EVOLUTION® STEMMED CS Femur with the EVOLUTION® MP CS Tibial Insert)
  • Decision to perform the study index surgery with the required study components is pre-determined regardless of the research;
  • Previously implanted subjects must be enrolled within 3 years (+ 6 months) of their study index surgery
  • Willing to voluntarily sign the informed consent form
  • Willing and able to comply with the protocol, able to read and complete the required forms, and willing and able to adhere to the requirements of the protocol through the 10-year postoperative follow-up visit.

Exclusion Criteria8

  • Skeletally immature (less than 21 years of age) at time of implantation
  • Has or had an overt infection at the time of implantation
  • Has or had inadequate neuromuscular status (e.g., prior paralysis, fusion, and/or inadequate abductor strength), poor bone stock, poor skin coverage around the joint which would make the procedure unjustifiable
  • Currently enrolled in another clinical investigation which could affect the endpoints of this protocol
  • Has or had documented substance abuse issues
  • Has or had an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study
  • Currently incarcerated or has impending incarceration
  • Has a medical condition, as judged by the Investigator, that would interfere with the subject's ability to comply with the requirements of the protocol

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEEVOLUTION® Revision Tibial System and EVOLUTION® Stemmed CS Femur with the EVOLUTION® MP CS Tibial Insert

Primary knee arthroplasty or a revision knee that requires a revision procedure.


Locations(1)

Gaetano Pini Orthopedic Institute

Milan, Piazza C. Ferrari 1 20122 Milan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06142669


Related Trials